Acadia Pharmaceuticals
ACAD
ACAD
203 hedge funds and large institutions have $3.34B invested in Acadia Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less call options, than puts
Call options by funds: $29.6M | Put options by funds: $40.6M
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
203
Holding in Top 10
2
Calls
$29.6M
Puts
$40.6M
Top Buyers
| 1 | +$102M | |
| 2 | +$21.9M | |
| 3 | +$15.4M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$14.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.2M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$31.5M | |
| 3 | -$28.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.6M |
| 5 |
JP
Jana Partners
New York
|
-$14.5M |